Donor stem cell transplantation associated with survival benefit

An analysis of previous studies indicates that allogeneic stem cell transplantation (SCT) (stem cells from a compatible donor) is associated with significant overall and relapse-free survival benefit among adult patients with intermediate- and poor-risk but not good-risk acute myeloid leukaemia in first complete remission, compared with nonallogeneic SCT therapies, according to an article in the 10 June issue of JAMA...

Read the whole article on

More from